MacroGenics | MGNX - Custo de Mercadoria Vendida

Preço das Ações
2.86
Mudança Diária
-0.04 -1.38%
Mensal
63.43%
Anual
43.36%
Q1 Previsão
2.91




Custo de Mercadoria Vendida Alterar Data
AbbVie USD 4.55B 757M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Genmab DKK 81M 23M 2025-12
Geron USD 1.31M 263K 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
J&J USD 7.97B 689M 2025-12
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 3.32B 531M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Xencor USD 61.66M 50.95M 2025-06